Function of gaseous hydrogen sulfide in liver fibrosis

被引:5
|
作者
Lee, Jae-Ho [1 ]
Im, Seung-Soon [1 ]
机构
[1] Keimyung Univ, Dept Physiol, Sch Med, Daegu 42601, South Korea
关键词
CBS; CSE; Hydrogen sulfide; Liver fibrosis; Metabolism; MPST; ISCHEMIA-REPERFUSION INJURY; CYSTATHIONINE-BETA-SYNTHASE; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE; OXIDATIVE STRESS; GAMMA-LYASE; AUTOPHAGY; DISEASE; H2S; GLUCONEOGENESIS; METABOLISM;
D O I
10.5483/BMBRep.2022.55.10.124
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Over the past few years, hydrogen sulfide (H2S) has been shown to exert several biological functions in mammalian. The endogenous production of H2S is mainly mediated by cystathi-one beta-synthase, cystathione gamma-lyase and 3-mercaptopyruvate sul-fur transferase. These enzymes are broadly expressed in liver tissue and regulates liver function by working on a variety of molecular targets. As an important regulator of liver function, H2S is critically involved in the pathogenesis of various liver diseases, such as non-alcoholic steatohepatitis and liver cancer. Targeting H2S-generating enzymes may be a therapeutic strate-gy for controlling liver diseases. This review described the func-tion of H2S in liver disease and summarized recent characterized role of H2S in several cellular process of the liver. [BMB Reports 2022; 55(10): 481-487]
引用
收藏
页码:481 / 487
页数:7
相关论文
共 50 条
  • [21] BIOMARKERS IN CYSTIC FIBROSIS: ROLE OF HYDROGEN SULFIDE
    Kilaikode, S.
    Gardner, A.
    Kevil, C.
    Scott, K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (02) : 667 - 667
  • [22] Involvement of hydrogen sulfide in the progression of renal fibrosis
    Wang, Yu
    Xing, Qi-Qi
    Tu, Jing-Ke
    Tang, Wen-Bin
    Yuan, Xiang-Ning
    Xie, Yan-Yun
    Wang, Wei
    Peng, Zhang-Zhe
    Huang, Ling
    Xu, Hui
    Qin, Jiao
    Xiao, Xiang-Cheng
    Tao, Li-Jian
    Yuan, Qiong-Jing
    CHINESE MEDICAL JOURNAL, 2019, 132 (23) : 2872 - 2880
  • [23] Involvement of hydrogen sulfide in the progression of renal fibrosis
    Wang Yu
    Xing Qi-Qi
    Tu Jing-Ke
    Tang Wen-Bin
    Yuan Xiang-Ning
    Xie Yan-Yun
    Wang Wei
    Peng Zhang-Zhe
    Huang Ling
    Xu Hui
    Qin Jiao
    Xiao Xiang-Cheng
    Tao Li-Jian
    Yuan Qiong-Jing
    中华医学杂志英文版, 2019, 132 (23) : 2872 - 2880
  • [24] Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis
    Zhang, Shufang
    Pan, Chuli
    Zhou, Feifei
    Yuan, Zhi
    Wang, Huiying
    Cui, Wei
    Zhang, Gensheng
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2015, 2015
  • [25] Low Temperature Catalytic Decomposition of Hydrogen Sulfide into Hydrogen and Diatomic Gaseous Sulfur
    A. N. Startsev
    O. V. Kruglyakova
    Yu. A. Chesalov
    S. Ph. Ruzankin
    E. A. Kravtsov
    T. V. Larina
    E. A. Paukshtis
    Topics in Catalysis, 2013, 56 : 969 - 980
  • [26] Low Temperature Catalytic Decomposition of Hydrogen Sulfide into Hydrogen and Diatomic Gaseous Sulfur
    Startsev, A. N.
    Kruglyakova, O. V.
    Chesalov, Yu. A.
    Ruzankin, S. Ph.
    Kravtsov, E. A.
    Larina, T. V.
    Paukshtis, E. A.
    TOPICS IN CATALYSIS, 2013, 56 (11) : 969 - 980
  • [27] Production of the gaseous signal molecule hydrogen sulfide in mouse tissues
    Linden, David R.
    Sha, Lei
    Mazzone, Amelia
    Stoltz, Gary J.
    Bernard, Cheryl E.
    Furne, Julie K.
    Levitt, Michael D.
    Farrugia, Gianrico
    Szurszewski, Joseph H.
    JOURNAL OF NEUROCHEMISTRY, 2008, 106 (04) : 1577 - 1585
  • [28] The gaseous transmitter hydrogen sulfide in the human choroid: first results
    Schroedl, Falk
    Platzl, Christian
    Heindl, Ludwig M.
    Kaser-Eichberger, Alexandra
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [29] Experimental study of the transport of chalcophile metals in gaseous hydrogen sulfide
    Bychkov, A. Yu.
    Nikolaeva, I. Yu.
    GEOCHEMISTRY INTERNATIONAL, 2013, 51 (05) : 413 - 416
  • [30] Therapeutic applications of the gaseous mediators carbon monoxide and hydrogen sulfide
    Bannenberg, Gerard L.
    Vieira, Helena L. A.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (05) : 663 - 682